Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Borget

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Mayo Clinic Proceedings. Digital Health|April 10, 2025
International Market Access Strategies for Artificial Intelligence-Based Medical Devices: Can We Standardize the Process to Faster Patient Access?Line Farah, Isabelle Borget, Nicolas Martelli
Expert Review of Pharmacoeconomics & Outcomes Research|June 15, 2013
Treatment of lung cancer: will financial issues become a criterion of choice?Alain Vergnenegre, Isabelle Borget, Christos Chouaid
Current Opinion in Supportive and Palliative Care|November 6, 2013
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancerSami Antoun, Isabelle Borget, Emilie Lanoy
Nature Reviews. Endocrinology|June 21, 2022
Post-operative radioactive iodine administration in patients with low-risk thyroid cancerSophie Leboulleux, Isabelle Borget, Martin Schlumberger
The Lancet. Diabetes & Endocrinology|August 26, 2018
Radioactive iodine ablation in low-risk thyroid cancer - Authors' replySophie Leboulleux, Isabelle Borget, Martin Schlumberger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Targeted therapies in non-small-cell lung cancer management: no cost-effective strategies?Christos Chouaid, Isabelle Borget, Alain Vergnenegre
Nature Clinical Practice. Endocrinology & Metabolism|October 3, 2007
Health-related quality of life--an economist's perspectiveGérard de Pouvourville, Isabelle Borget, Martin Schlumberger
The New England Journal of Medicine|June 1, 2022
Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer. ReplySophie Leboulleux, Martin-Jean Schlumberger, Isabelle Borget
Advances in Therapy|February 27, 2015
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in FranceFlorian Scotte, Nicolas Martelli, Alexandre Vainchtock, et al.
The Lancet. Diabetes & Endocrinology|March 10, 2022
Global thyroid estimates in 2020Livia Lamartina, Sophie Leboulleux, Isabelle Borget, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Mayo Clinic Proceedings. Digital Health|April 10, 2025
International Market Access Strategies for Artificial Intelligence-Based Medical Devices: Can We Standardize the Process to Faster Patient Access?Line Farah, Isabelle Borget, Nicolas Martelli
Expert Review of Pharmacoeconomics & Outcomes Research|June 15, 2013
Treatment of lung cancer: will financial issues become a criterion of choice?Alain Vergnenegre, Isabelle Borget, Christos Chouaid
Current Opinion in Supportive and Palliative Care|November 6, 2013
Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancerSami Antoun, Isabelle Borget, Emilie Lanoy
Nature Reviews. Endocrinology|June 21, 2022
Post-operative radioactive iodine administration in patients with low-risk thyroid cancerSophie Leboulleux, Isabelle Borget, Martin Schlumberger
The Lancet. Diabetes & Endocrinology|August 26, 2018
Radioactive iodine ablation in low-risk thyroid cancer - Authors' replySophie Leboulleux, Isabelle Borget, Martin Schlumberger
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Targeted therapies in non-small-cell lung cancer management: no cost-effective strategies?Christos Chouaid, Isabelle Borget, Alain Vergnenegre
Nature Clinical Practice. Endocrinology & Metabolism|October 3, 2007
Health-related quality of life--an economist's perspectiveGérard de Pouvourville, Isabelle Borget, Martin Schlumberger
The New England Journal of Medicine|June 1, 2022
Thyroidectomy without Radioiodine in Low-Risk Thyroid Cancer. ReplySophie Leboulleux, Martin-Jean Schlumberger, Isabelle Borget
Advances in Therapy|February 27, 2015
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in FranceFlorian Scotte, Nicolas Martelli, Alexandre Vainchtock, et al.
The Lancet. Diabetes & Endocrinology|March 10, 2022
Global thyroid estimates in 2020Livia Lamartina, Sophie Leboulleux, Isabelle Borget, et al.
Pageof 14